WVE - ウェ―ブ・ライフ・サイエンシズ （WAVE Life Sciences Ltd.）

CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, will host a live webcast and conference call at 8:30 a.m. ET on Wednesday, May 3, 2023, to review the company’s first quarter 2023 financial results and provide business updates.

Published preclinical data demonstrate unprecedented Ago2 loading following administration of single subcutaneous siRNA dose, leading to improved potency and durability in vivo versus comparator siRNA formats

Wave Life Sciences Ltd. (NASDAQ:WVE – Get Rating) saw a significant growth in short interest in March. As of March 31st, there was short interest totalling 2,020,000 shares, a growth of 32.0% from the March 15th total of 1,530,000 shares. Based on an average trading volume of 428,200 shares, the short-interest ratio is presently 4.7 […]

Benzinga Pro data, WAVE Life Sciences (NASDAQ: WVE ) reported Q4 sales of $1.24 million. Earnings fell to a loss of $43.71 million, resulting in a 12.06% decrease from last quarter. WAVE Life Sciences collected $285 thousand in revenue during Q3, but reported earnings showed a $39.00 million loss. Why Is ROCE Significant? Earnings data without context is not clear and can be difficult to base trading decisions on. Return on Capital Employed (ROCE) helps to filter signal from noise by measuring yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests … Full story available on Benzinga.com

The following slide deck was published by Wave Life Sciences Ltd.

CAMBRIDGE, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that management will host a live webcast and conference call at 8:30 a.m. ET on Wednesday, March 22, 2023, to discuss the company’s fourth quarter and full year 2022 financial results and provide a business update.

CAMBRIDGE, Mass., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the SVB Securities Global Biopharma Conference at 10:00 a.m. ET on Thursday, February, 16, 2023.

During the last session, Wave Life Sciences Ltd. (NASDAQ:WVE)’s traded shares were 0.68 million, with the beta value of the company hitting -0.90. At the end of the trading day, the stock’s price was $4.76, reflecting an intraday gain of 6.73% or $0.3. The 52-week high for the WVE share is $7.12, that puts it … What To Expect As Wave Life Sciences Ltd. (NASDAQ: WVE) Delivers An 27.27% Gain In 6 Months Read More »

Wave Life Sciences Ltd. (NASDAQ:WVE) price on Friday, January 13, rose 4.00% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $5.46. A look at the stock’s price movement, the close in the last trading session was $5.25, moving within a range at $5.13 and $5.695. The beta … Wave Life Sciences Ltd. (NASDAQ:WVE) Stock Could Be Worth Considering Read More »

Wave Life Sciences Ltd. (NASDAQ:WVE) marked $5.25 per share on Thursday, down from a previous closing price of $5.26. While Wave Life Sciences Ltd. has underperformed by -0.19%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, WVE rose by 93.73%, with highs and lows ranging from […]

As of Wednesday, Wave Life Sciences Ltd.’s (NASDAQ:WVE) stock closed at $4.21, up from $4.10 the previous day. While Wave Life Sciences Ltd. has overperformed by 2.68%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, WVE rose by 6.05%, with highs and lows ranging from $5.31 […]

The share price of Wave Life Sciences Ltd. (NASDAQ:WVE) fell to $3.64 per share on Friday from $4.17. While Wave Life Sciences Ltd. has underperformed by -12.71%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, WVE fell by -23.21%, with highs and lows ranging from $5.31 […]

Wave Life Sciences Ltd. (NASDAQ:NASDAQ:WVE) Q3 2022 Earnings Conference Call November 10, 2022 08:30 AM ET Company Participants Kate Rausch - Head, Investor Relations Paul Bolno - President…

The following slide deck was published by Wave Life Sciences Ltd.

SINGAPORE (AP) _ Wave Life Sciences Pte. Ltd. (WVE) on Thursday reported a loss of $39 million in its third quarter. The Singapore-based company said it had a loss of 42 cents per share. The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks …